Teleflex Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
472 / 663
Position in country
11381 / 14179
Return on Assets, %
5
-11.9
Net income margin, %
4
-12.5
EBITDA margin, %
25.7
-2.5
Debt to Equity, %
40.8
15
Intangible assets and goodwill, %
71.9
3.9
Revenue CAGR 3Y, %
5.4
12.6
Total Equity change 1Y, %
10.4
0
Revenue Y, % chg
6.5
4.6
P/E
28.3
28.3
P/BV
2.2
1.7
P/S
3.3
3.7
EV/S
3.9
3.2
EV/EBITDA
14.5
-0.2
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
23.5
66.5
Forward P/E
15.1
19.2
Dividend Yield, %
0.6
1.8
Forward Dividend Yield, %
0.6
0.2
Expected dividend per share
1.3
0
Payout Ratio, %
17.8
17.3
Dividend Ex Date
2024-02-29
Competitors
Ranks
-
Dexcom Inc
00%
-
Boston Scientific Corp
00%
-
Intuitive Surgical Inc
00%
-
Stryker Corp
00%
-
Edwards Lifesciences Corp
00%
-
IDEXX Laboratories Inc
00%
-
Abbott Laboratories
00%
-
GE Healthcare Technologies Inc
00%
-
Becton Dickinson and Co
00%
-
Teleflex Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
10100.3
Ticker
TFX.N
ISIN
US8793691069
IPO date
1980-03-17
Availability on Russian exchanges
Yes
Reporting for
2024-02-23
Date fact. publication of reports
2023-12-31
Company Description
Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas; Europe, Middle East and Africa (EMEA); Asia (Asia Pacific), and Original Equipment Manufacturer and Development Services (OEM). Its product categories include vascular access, anesthesia, interventional, surgical, interventional urology, and urology. The Company's specialty product line of urology products provides bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: